Osaka University Venture Fund and Nippi Co. invest in Matrixome, a stem-cell venture

The venture will focus on the use of the recombinant laminin 511E8 fragment which was developed by Kyoto University iPS Cell Research members and is now marketed by Nippi, a collagen product company. Matrixome will develop various equipment coated with this laminin derivative for use in cell culture technology.

Nippi news release, February 1, 2016

Most popular posts: